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REVIEWBlood culture-based diagnosis of bacteraemia: state of the artO. Opota1, A. Croxatto1, G. Prod’hom1 and G. Greub1,2
1) Institute of Microbiology and 2) Infectious Diseases Service, University of Lausanne and University Hospital Centre, Lausanne, SwitzerlandAbstractBlood culture remains the best approach to identify the incriminating microorganisms when a bloodstream infection is suspected, and to
guarantee that the antimicrobial treatment is adequate. Major improvements have been made in the last years to increase the sensitivity
and speciﬁcity and to reduce the time to identiﬁcation of microorganisms recovered from blood cultures. Among other factors, the
introduction in clinical microbiology laboratories of the matrix-assisted laser desorption ionization time-of-ﬂight mass spectrometry
technology revolutionized the identiﬁcation of microorganisms whereas the introduction of nucleic-acid-based methods, such as DNA
hybridization or rapid PCR-based test, signiﬁcantly reduce the time to results. Together with traditional antimicrobial susceptibility
testing, new rapid methods for the detection of resistance mechanisms respond to major epidemiological concerns such as methicillin-
resistant Staphylococcus aureus, extended-spectrum β-lactamase or carbapenemases. This review presents and discusses the recent
developments in microbial diagnosis of bloodstream infections based on blood cultures.
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E-mail: Gilbert.Greub@chuv.chIntroductionBloodstream infections (BSIs) are severe diseases characterized
by a high morbidity and mortality, which is directly related with
the delay in administration of the ﬁrst adequate anti-infectious
agent [1–7]. Empirical anti-infectious treatments are chosen
on the basis of the clinical and epidemiological data and are
started immediately after the sampling of blood bottles; how-
ever, until microbiological documentation, their adequacy
cannot be guaranteed [8–10], especially in the context of an
increasing rate of multidrug-resistant organisms [11]. Rapid
microbiological investigations— identiﬁcation of the causative
agent and antimicrobial susceptibility testing (AST)–are there-
fore very important: 1) to adjust the anti-infectious therapy andClinical Microbiology and Infection © 2015 European Society of Cto avoid inefﬁcient treatment, 2) to reduce the spectrum of the
anti-infectious therapy so as to limit the selection of resistant
strains and 3) to limit the toxicity and negative impact on
beneﬁcial bacteria of some broad-spectrum antibiotics or
combined therapy. The quantity of microbes present in the
blood during BSIs ranges from 1 to 10 CFU/mL [12–15] to
1 × 103 and 1 × 104 CFU/mL [16]. Blood cultures currently
represent the main method to determine the aetiology of a BSI
because they are highly sensitive and easy to perform. The
sensitivity of blood cultures is largely related to the volume of
the sample. For adults, one blood sampling generally represents
up to 20 mL of blood used to inoculate two bottles (one aer-
obic bottle and one anaerobic bottle). Before antibacterial
treatment two to four blood cultures, i.e. 40 mL to 80 mL of
blood are necessary to detect a causative agent in 80% to 96%
of bacteremias [17,18]. Upon blood-culture positivity, the ﬁrst
step is to perform a Gram staining with a blood-culture aliquot.
This is a mandatory analysis to conﬁrm the presence of bac-
teria/fungi in the blood bottle. If microbes are present, the
morphotype provides a ﬁrst hint on the aetiology of the
infection. Then microbe identiﬁcation can be achieved using
various approaches that are described and discussed in thisClin Microbiol Infect 2015; 21: 313–322
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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positive blood culture using nucleic-acid-based methods such as
hybridization and microarray or 3) after a bacterial enrichment
and puriﬁcation step to obtain a ‘bacterial pellet’, suitable for a
variety of approaches including matrix-assisted laser desorption
ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS).Blood-culture sampling and technologiesStandard bottles containing rich media have been designed for
aerobic and anaerobic growth conditions, respectively. They
are designed for up to 10 mL of blood. However, because of the
difﬁculty of obtaining large volumes of blood, speciﬁc paediatric
blood bottles have been designed for the culture of volumes <3
mL. To neutralize antibiotics given prior to sampling, charcoal
or resins have been introduced in speciﬁc bottles (Table 1).
Lytic agents added in some growth media promote the re-
covery and growth of organisms that have been endocytosed by
phagocytes. Standard incubation time is 5 days, which is sufﬁ-
cient for the recovery of the majority of organisms including the
HACEK group of fastidious bacteria (Haemophilus, Aggregati-
bacter, Cardiobacterium, Eikuenella and Kingella) bacteria and
Brucella spp. [19,20]. However, the incubation time should be
increased for slow-growing organisms such as fungi and Myco-
bacteria spp.; the latter being grown in bottles containing Mid-
dlebrook 7H9. Modern laboratories rely on automated
incubators (Table 1) including continuous monitoring for pos-
itive bottle detection, which signiﬁcantly reduces the working
load, the incubation time and the contamination rate. Blood-
culture positivity is generally detected by following CO2 pro-
duction by growing microorganisms that trigger a pH increase
visualized by colour changes, ﬂuorescence signal or red-ox
variations.TABLE 1. Main automated blood culture incubation systems curre
System (Manufacturer) Main blood-culture media and c
BD BACTEC
(BD Diagnostics, Franklin Lakes, NJ, USA)
Standard aerobic and anaerobic brot
Media containing resin particles
Media speciﬁcally designed for small
Media containing a lysing agent to inc
of organisms phagocytosed
Media optimized for the growth of m
Speciﬁc algorithms for fastidious org
(e.g. Haemophilus spp. and Neisser
BacT/ALERT 3D
(bioMérieux, Durham, NC, USA)
Plastic bottles
Standard aerobic and anaerobic brot
Media containing activated charcoal p
Media speciﬁcally designed for small
Media supplemented with Middlebro
Enriched media
VersaTREK,
(TREK Diagnostic Systems, ThermoFisher
Scientiﬁc, Waltham, MA, USA)
Standard aerobic and anaerobic brot
from 0.1 to 10 mL, optimized to
aThe presence of charcoal particles prevent the use of the pellet for direct identiﬁcation fro
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectInterpretation of positive blood cultures:
contamination versus bloodstream infectionContamination that represents up to one-third of positive
blood cultures can occur when microbes that are not present
in the bloodstream are introduced into the bottle during the
blood sampling [21]. Even if blood cultures are drawn under
aseptic conditions, contaminations are often due to organisms
that can be present in the environment and that can be part
of the skin ﬂora, such as coagulase-negative staphylococci, the
third most prevalent microbe identiﬁed in blood cultures in
our tertiary-care university hospital (Fig. 1), and other or-
ganisms with low or absent virulence towards humans such as
Micrococcus spp., Propionibacterium acnes, most Bacillus spp. and
most Corynebacterium spp. [21]. Interestingly, the rate of
contamination inversely correlates with the blood volume
[21,22]. A small sample volume might increase the concen-
tration of contaminants or might be associated with difﬁculties
in maintaining sterile conditions due to poor venous access
[21,22]. Interestingly, peripheral venepuncture, arterial access
or central venous accesses are associated with different
contamination rates of 36%, 10% and 7%, respectively [21].
For venepuncture, a promising approach to reduce to <30%
the contamination rate is named the ‘initial specimen diversion
technique’, in which the ﬁrst milliliter of blood (potentially
containing bacteria not killed by skin surface antisepsis) is
discarded or used for other purposes [23,24]. Nevertheless
the speciﬁcity of blood culture for the diagnosis of BSI re-
mains high as most of the top microbes recovered from
positive blood cultures are primarily pathogens such as
Escherichia coli, Staphylococcus aureus or Pseudomonas aerugi-
nosa respectively second, fourth and ﬁfth positions, respec-
tively (Fig. 1).ntly commercially available
haracteristics Positivity detection system
h media
blood volume inoculation
rease the recovery
ycobacteria
anisms
ia spp.)
Fluorescent sensor of CO2 production
h media
articlesa or resin
blood volume inoculation
ok 7H9 for microbacteria growth
Colorimetric sensor of CO2 production
h media for samples
minimize the impact of antibiotics
Monitoring of redox variations
m positive blood culture using MALDI-TOF MS.
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FIG. 1. Top 20 microbes identiﬁed from positive blood cultures during 1 year. Data from our 1000-bed tertiary-care university hospital during the
year 2013. The pie chart represents the distribution per morphotype of all the microorganisms (total 16 682 identiﬁcations).
CMI Opota et al. Diagnostic of bacteraemia 315Together with the clinical signs and symptoms, several pa-
rameters can help to identify precisely the signiﬁcance of pos-
itive blood cultures: 1) the number of positive bottles, the
number of positive blood-culture pairs as well as the propor-
tion of positive cultures [25], 2) the site of sampling—catheter
versus venous puncture, and 3) the time to positivity, including
the differential time to positivity between pairs collected from
different sampling sites [26]. For this reason, international
guidelines recommend drawing several sets of blood bottles
[27]. Increasing the number of blood cultures increases the
sensitivity through the increased total volume collected [28].
Blood-culture sampling should be repeated because bacter-
aemia often occurs intermittently. This is not the case of
endocarditis or septic thrombophlebitis, where all the bottles
are generally positive with pyogenic bacteria such as S. aureus
and Streptococcus pyogenes.
When contamination is excluded, the organism detected and
identiﬁed in the blood culture is probably present in the
bloodstream at the time of sampling, which deﬁnes a bacter-
aemia (or fungaemia). Bacteraemia or fungaemia can beClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologytransient or sustained. Transient bacteraemia corresponds to a
single episode of positive blood cultures due to the presence of
microorganism during a short time-lapse in the bloodstream
(less than 30 min). They are generally caused by the manipu-
lation of contaminated mucosa or invasive respiratory, gastro-
intestinal or urogenital acts [29]. Conversely, a ﬁnding of
multiple positive bottles drawn at different times is a sign of
sustained bacteraemia (fungaemia). Sustained positive blood
cultures are encountered in the presence of endovascular in-
fections such as endocarditis. In such cases a high number of
blood cultures become positive without any difference in the
time to positivity for bottles drawn simultaneously from
different sites. In contrast, a catheter infection is suspected
when blood cultures drawn from a catheter become positive
more than 2 h before blood culture drawn from a ven-
epuncture. This time to positivity difference exhibits an overall
sensitivity of 91% and a speciﬁcity of 94% for the diagnosis of
catheter infection [30]. The catheter can be removed and
cultured by plating the catheter tip using the Maki roll-on semi-
quantitative method [31]. Sustained bacteraemia should beand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 313–322
316 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMIdifferentiated from persistent bacteraemia, which is deﬁned by
the persistence of positive blood cultures despite the intro-
duction of an anti-infectious treatment. Persistent bacteraemia
(fungaemia) is generally due to organisms resistant to the pre-
scribed antibiotic, to the presence of a second organism or to
the site of infection being inaccessible to the antibiotic (e.g.
septic thrombosis).Identiﬁcation and AST approaches requiring
a pure subcultureAfter the Gram-staining examination, the positive blood culture
can be plated to ensure pure culture (isolated colonies) that can
be analysed using conventional biochemical methods, MALDI-
TOF MS and/or nucleic-acid based methods such as PCR and
gene sequencing (Fig. 2). A 12-h to 24-h incubation period is
generally required to obtain enough isolated colonies for
biochemical characterization, whereas relatively short in-
cubations (<6 h) are often long enough to obtain pure sub-
cultures. For this reason, MALDI-TOF MS, the current best
method for rapid bacterial identiﬁcation (see section MALDI-
TOF MS) has been tested on colonies obtained after short in-
cubation on solid medium. Idelevich et al. reported that aClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectsubculture shorter than 6 h yielded species identiﬁcation in
97.6% of the case for Gram-negative aerobic rods and 64.0% of
Gram-positive aerobic cocci using MALDI-TOF MS [32]. The
mean subculture time on agar plate needed to achieve bacterial
identiﬁcation at the species level was 5.9 h for Gram-positive
aerobic cocci and 2.0 h for Gram-negative aerobic rods [32].
Similarly Verroken et al. reported 81.1% correct identiﬁcations
using MALDI-TOF MS on a 5-h brief culture of monomicrobial
blood cultures. In addition a correct identiﬁcation of one of the
two pathogens was achieved in 82.7% of the polymicrobial
blood cultures [33]. AST performed directly from a positive
blood bottle is not recommended but can be achieved on a
bacterial pellet preparation from the positive blood bottle (see
section Identiﬁcation and antimicrobial susceptibility testing using a
blood-culture microbial pellet) or via a brief subculture. A short
subculture (2.4 h for Gram-negative bacteria and 3.8 h for
Gram-positive bacteria) provided reliable AST using the auto-
mated device VITEK2 (bioMérieux SA, Marcy l’Étoile, France).
The total time to result from positive blood cultures was 11.2 h
and 13.6 h for Gram-negative rods and Gram-positive cocci,
respectively [34]. Automated systems allow the testing of a high
number of antibiotics at the same time, the interpretation of the
result is automated and internal expert systems are able to
detect speciﬁc resistance mechanisms such as extended-FIG. 2. Methods to identify microor-
ganisms from positive blood cultures.
When a blood culture is detected as
positive, the ﬁrst step is to perform a
Gram staining with a sub-sample from
the blood-culture bottle to conﬁrm the
presence of microbes and to deter-
mine the morphotype. The Gram
staining allows disclosure of the pres-
ence of polymicrobial infections. Then
the pathogen identiﬁcation can be
achieved: (a) Directly from positive
blood culture using nucleic-acid-based
methods, (b) via a subculture using
phenotypic methods or via short sub-
cultures that are suitable for matrix-
assisted laser desorption/ionization
time-of-ﬂight mass spectormetry
(MALDI-TOF MS) analysis and some
antimicrobial susceptibility testing
(AST) and (c) using a puriﬁed bacterial
pellet also suitable for MALDI-TOFMS
analysis and some AST.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 313–322
CMI Opota et al. Diagnostic of bacteraemia 317spectrum β-lactamase (ESBL) and carbapenemases. Further
studies performed on a higher number of pathogen are
necessary to conﬁrm the reliability of brief culture for AST with
the VITEK2 and other automated devices such as the MicroScan
Walk Away (Siemens Healthcare, Sacramento, CA, USA) and
the Phoenix (Becton Dickinson, Heidelberg, Germany). In
addition, VITEK2 does not provide an exact MIC, in contrast to
the MicroScan Walk Away and the Phoenix.Nucleic-acid-based methods that can be used
directly on positive blood culturesMolecular methods are generally faster than phenotypic ap-
proaches because they are culture independent. However, the
use of ampliﬁcation-based nucleic acid methods such as PCR
has to face several limitations associated with a blood sample: 1)
presence of PCR inhibitors, 2) presence of a high quantity of
non-microbial nucleic acids, 3) presence of contaminant DNA,
and 4) persistence of DNA from dead microbes [35]. Thanks to
recent advances in nucleic acid extraction and ampliﬁcation,
several PCR-based methods for the diagnosis of BSI directly
from whole blood are now available. These methods are pre-
sented in a separate detailed review [35]. In the present review
we will focus on nucleic-acid-based methods that are specif-
ically dedicated for positive blood cultures such as probes hy-
bridization and microarrays and some rapid PCR-based tests.
Probes hybridization and microarrays that are non-
ampliﬁcation-based nucleic acid methods are less inﬂuenced
by inhibitors and less prone to contamination but they require a
high bacterial or fungal load. Hence these methods are used on
positive blood cultures in which the bacterial load can reach
1 × 106 to 2 × 108 for Gram-positive cocci and 2 × 107 to
1 × for Gram-negative bacilli (Fig. 2) [35–37].
Fluorescence in situ hybridization (FISH) that comprises the
speciﬁc binding of ﬂuorescent nucleic acid probes on comple-
mentary pathogen DNA sequences—16S rRNA for bacteria
and 18S rRNA for fungi—can be performed directly from the
positive blood cultures. The speciﬁc binding is observed using a
ﬂuorescence microscope. The choice of the probe is dependent
on the Gram staining: staphylococci probes (S. aureus/coagu-
lase-negative staphylococci), enterococci probes (Enterococcus
faecalis/Enterococcus faecium), Gram-negative bacteria probes
(Escherichia coli/Pseudomonas aeruginosa/Klebsiella pneumoniae),
yeast probes (Candida albicans/Candida glabrata/Candida para-
psilosis/Candida krusei) for instance. The commercial solutions
PNA-FISH and Quick-FISH (AdvanDx, Woburn, MA, USA)
display a time to result of about 1.5 to 3 h with a sensitivity and
speciﬁcity of 97–100% and 90–100%, respectively (Table 2)Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology[38–43]. The AccuProbe system (Gen-Probe, San Diego, CA,
USA) is based on a DNA probe that can detect S. aureus,
Streptococcus pneumoniae, Enterococcus spp. and group A and B
streptococci. The sensitivity and speciﬁcity are above 97%, with
the exception of the S. aureus probes that demonstrate a
sensitivity of 99.8% and a speciﬁcity of 80.8% [44,45].
Microarrays allow the detection of a limited number of
species which cover 90–95% of all the pathogens causing BSI.
The turnaround time is about 2.5–4 h with sensitivity ranging
from 10 to 105 CFU/mL [46]. In contrast to FISH, microarrays
generally contain probes for the detection of resistance genes
such as mecA, vanA/vanB and blaKPC. For example, the Verigene
system (Nanosphere, Northbrook, IL, USA) comprises two
distinct kits for the detection of 12 Gram-positive and nine
Gram-negative bacterial species with a sensitivity ranging from
81 to 100% and a speciﬁcity higher than 98% [47,48]. The
Prove-it Sepsis assay (Mobidiag, Esbo, Finland) combines a PCR
with a microarray for a turnaround time of 3.5 h, and has 95%
sensitivity and 99% speciﬁcity (Table 2) [49].
Rapid PCR-based tests that allow the detection and identi-
ﬁcation of methicillin-sensitive S. aureus (MSSA) and methicillin-
resistant S. aureus (MRSA) have been developed to blood cul-
tures because of the clinical impact and epidemiological
concern of this pathogen [50,51]. MSSA/MRSA rapid PCR-
based detection systems such as GeneXpert MRSA/SA BC
Assay (Cepheid, Sunnyvale, CA, USA) [52,53] and the StaphSR
assay (BD GeneOhm, San Diego, CA, USA) [54,55] are based
on multiplex real-time PCR to detect S. aureus and the presence
of the mecA gene. The results are obtained in approximately
1.5 h. The FilmArray (Idaho Technology, Salt Lake City, UT,
USA) is a multiplex PCR-based system designed to detect 25
microbes (90–95% of the pathogens involved in blood cultures)
and the resistance genes mecA, vanA and vanB and blaKPC [56].
Nucleic-acid-based methods signiﬁcantly reduce the turn-
around time of the microbial diagnosis of BSI, which represents
a beneﬁt for patient care. However, for the large-scale imple-
mentation of these technologies in clinical laboratories, efforts
have to be made to reduce the cost and the hands-on time of
some of these technologies, especially since the introduction of
MALDI-TOF MS.Subculture independent approaches:
identiﬁcation and antimicrobial susceptibility
testing using a blood-culture microbial pelletThe use of MALDI-TOF MS technology for the identiﬁcation of
microorganisms is among the major revolutions in clinical
microbiology laboratories during recent years. Microbialand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 313–322
TABLE 2. Characteristics of the commercially available systems for the identiﬁcation of microbes from positive blood culture
System
(Manufacturer) Methods
Time to
result
Microorganism
coverage
Resistance and
virulence
markers
Sensitivity
Speciﬁcity
Correlation
with conventional
methods (%) Comments References
PNA FISH and QuickFISH
(AdvanDx, Woburn, MA, USA)
FISH <1–3 hours 4 Gram positive
4 Gram negative
5 Fungi
0 97–100
90–100
96–99
+ : rapid, sensitive and speciﬁc
– : dependent on the choice
of the probes to be tested, no
resistance marker
[38,41,42,75–80]
AccuProbe
(Gen-Probe, San Diego,
CA, USA)
FISH <1 hour Staphylococcus aureus
Enterococcus spp.
Streptococcus pneumoniae
Streptococcus group A
Streptococcus group B
0 80.8–100
98.7–100
nr
+ : high speciﬁcity
– : variable sensitivity, no resistance
marker, limited number of publications
[44,45]
Verigene
(Nanosphere, Northbrook,
IL, USA)
Microarray 2.5 hours 12 Gram positive
9 Gram negative
mecA, vanA/B, KPC,
NDM, CTX-M,VIM,
IMP,OXA12
81–100
98–100
nr
+: detection of resistance markers,
good speciﬁcity
– : variable sensitivity, narrow
range of pathogens detected
[47,81–89]
Prove-it Sepsis (Mobidiag,
Esbo, Finland)
Microarray 3.5 hours 60 bacteria
13 fungi
mecA 95%
99%
nr
+ : sensitive and speciﬁc
– : limited number of publications
[49]
FilmArray
(Idaho Technology, Salt Lake
City, UT, USA)
Multiplex PCR 1 hour 8 Gram positive
11 Gram negative
5 Fungi
mecA, vanA/B, KPC 97–95
91–98
nr
+ : rapid, sensitive and speciﬁc
– : narrow range of pathogens
detected
[56,90–92]
Xpert MRSA/SA BC
(Cepheid, Sunnyvale, CA, USA)
Real-time PCR 1 hour S. aureus mecA 100
99–100
nr
+ : rapid, sensitive and speciﬁc
– : expensive
[52,53,93–95]
StaphSR assay
(BD GeneOhm, San Diego,
CA, USA)
Multiplex PCR 1–2 hours S. aureus mecA 96–100
95–98
nr
+ : rapid, sensitive and speciﬁc
– : expensive
[96,97]
StaphPlex
(Genaco Biomedical Products,
Huntsville, AL, USA)
Multiplex PCR +
Microarray
5 hours S. aureus mecA (+ PVL) 100
95–100
92
– : limited number of publications [98]
MALDI-TOF MS
Brucker Daltonics (Bremen, Germany)
bioMérieux (Marcy l’Etoile, France)
Mass-spectrometry <1 hour <1000a not in routine –
–
76–99
+ : rapid, sensitive and speciﬁc
– : signiﬁcant hands on time for
bacterial enrichment
[36,39,57,59,60,66,69]
Abbreviations: FISH, ﬂuorescence in situ hybridization; MALDI-TOF MS, matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry; nr, not reported.
aDependent on the mass-spectrum database.
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CMI Opota et al. Diagnostic of bacteraemia 319identiﬁcation usingMALDI-TOFMS is basedon the comparison of
a protein proﬁle obtained by mass spectrometry from a bacterial
or fungal sample with a database of proﬁles obtained from char-
acterized microbes [57,58]. MALDI-TOF MS is an accurate and
fast approach whose performance largely depends on a micro-
organism’s purity and quantity. Therefore, bacterial enrichment
and puriﬁcation procedures are required from positive blood
cultures, which contain high concentrations of non-microbial
material that may interfere with MALDI-TOF MS identiﬁcation
and AST. Several in-house and commercial methods have been
developed to isolate and concentrate microorganisms from pos-
itive blood cultures including lysis centrifugation methods
[59–61], saponin or equivalent mild detergent methods [62,63],
serum separator method [64] and the commercial MALDI Sep-
sityper Kit (Bruker Daltonics Inc., Billerica, MA, USA) [65]. These
pellet preparation protocols may not only be used for MALDI-
TOF MS identiﬁcation but also provide enough starting material
for other downstream applications including Gram staining, AST
[66] and rapid PCR-based tests [53].
MALDI-TOF MS on positive blood-culture pellet
The main MALDI-TOF MS systems commercially available, the
Autoﬂex II mass spectrometer (Bruker Daltonik) and Axima
Assurance system (Shimadzu Corporation, Kyoto, Japan) display
similar performance [57,58,67,68]. The performances of
MALDI-TOF MS identiﬁcation vary according to the enrichment
and puriﬁcation method (Table 2). In the study performed by
Prod’hom et al., 78.7% correct identiﬁcation by MALDI-TOF MS
was obtained from blood-culture pellets. Among samples giving
no reliable identiﬁcation by MALDI-TOF MS, 81% were blood-
culture-positive for Gram-positive bacteria including mainly
streptococci and coagulase-negative staphylococci [59]. Using a
differential centrifugation protocol, March-Rossello et al.
correctly identiﬁed 97.3% of Gram-negative bacteria and 98.4%
of Gram-positive bacteria [69]. Poor MALDI-TOF MS identiﬁ-
cations from blood-culture preparations are mainly observed
with difﬁcult-to-lyse bacteria (e.g. Klebsiella pneumoniae), closely
related bacterial species (e.g Streptococcus mitis group) and bac-
teria such as anaerobes that are poorly represented in the
MALDI-TOF MS database [57].
Antimicrobial susceptibility testing on positive blood-
culture pellet
Automated microbial system cards and manual disc diffusion
assays were directly used to perform AST from puriﬁed and/or
enriched microbial samples obtained from positive blood cul-
tures. Machen et al. performed a same-day AST by directly
inoculating the AST automated microbial system (VITEK 2)
with ﬁltered microorganisms from positive blood cultures. A
93.5% category agreement with tested antibiotics was obtainedClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologywith only 1.7% major errors (ME) and 1.3% very major errors
(VME) according to deﬁnitions given by the US Food and Drug
Administration for interpretive agreement results [70]. Similar
results were observed when the VITEK 2 was inoculated with
bacterial pellets obtained by ammonium chloride lysis centri-
fugation [66] or when the Phoenix system was inoculated with
bacteria harvested using serum separator tubes [71]. However,
some antibiotics known to present frequent discrepancies
compared with conventional approaches need to be conﬁrmed
by disc diffusion assays and/or gradient diffusion methods
directly performed from the same blood culture bacterial
preparations [66].
The emergence of broad-spectrum antibiotic resistance
mechanisms triggered the development of methods allowing
rapid detection of ESBL and carbapenemase activities on blood
cultures positive for Gram-negative bacteria. Using a Triton
lysis–centrifugation method, ESBL activities can be directly and
rapidly (less than 1 h) detected from spiked blood cultures using
the ESBL Nordmann/Dortet/Poirel (ESBL NDP) test with 100%
sensitivity and speciﬁcity [72]. Interestingly, the ESBL NDP test
applied to blood-culture pellets showed higher performance
compared with the same test performed on bacteria grown on
agar plates, which exhibited a 100% speciﬁcity; the decreased
sensitivity (92.6%) is due to the poor performance of the test
(25% sensitivity) for the detection of non-CTX-M ESBL pro-
ducers. The higher performance observed with this test applied
on blood culture samples is probably explained by the very high
bacterial inoculum recovered from positive blood cultures.
Another approach to detect ESBLs from positive blood cultures
is the chromogenic cephalosporin HMRZ-86 βLACTA test (Bio-
Rad, Marnes-la-Coquette, France) exhibiting a 100% sensitivity
and speciﬁcity following a 2-h subculture in tryptone soya broth
to prevent inhibition of the test by lysed blood [73]. Hence in
Lausanne, we applied it on puriﬁed bacterial pellets with accurate
results (Prod’hom et al. submitted). The detection of carbape-
nemase activity from positive blood cultures can be performed
with the Carba NDP with 97.9% sensitivity and 100% speciﬁcity
test following a 3-h selective enrichment in brain–heart infusion
containing imipenem [74]. A lower sensitivity (91.3%) was
observed with OXA-48 producers whereas 100% of sensitivity
was obtained with other classes of carbapenemases.
Rapid PCR-based tests on positive blood-culture pellet
Rapid PCR-based tests, such as the GeneXpert MRSA/SA BC
Assay, can be applied on both native and microbial puriﬁed and
enriched fractions of positive blood cultures (Fig. 2). The Gen-
eXpert MRSA/SA test was applied to S. aureus blood culture
bacterial pellets identiﬁed by MALDI-TOF MS and showed 99%
sensitivity and 100% speciﬁcity, allowing a signiﬁcant reduction of
anti-MRSA antibiotics misuse from 26.1% to 8.1% [53].and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 313–322
320 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMIConclusionsNew technologies and new methods for the diagnosis of posi-
tive blood cultures allow a signiﬁcant reduction of the turn-
around time for both identiﬁcation and AST, with a positive
impact on the management of patients suffering from BSIs.
Some of these approaches such as microbial enrichment via
centrifugation require signiﬁcant hands on time, which may
hinder their implementation in laboratories with limited human
resources. Hence, the emergence of new laboratory method-
ologies and new laboratory automated technologies, should
help the implementation of these new diagnostic approaches.
This should also be accompanied by signiﬁcant efforts in
increasing human resources.
The example of recent developments in the diagnosis of BSIs
highlights the importance of a dynamic research and development
process in diagnostic laboratories that promote innovation and
implementation of themost recent technologies for the beneﬁt of
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